Blueprint Medicines Appoints Lonnel Coats to Board of Directors
"We are pleased to welcome Lonnel to
Currently, Mr. Coats serves as president and chief executive officer and a member of the board of directors of
"I am delighted to join the
About
Logo - http://photos.prnewswire.com/prnh/20150605/221118LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/blueprint-medicines-appoints-lonnel-coats-to-board-of-directors-300215315.html
SOURCE
Investor Relations: Hannah Deresiewicz, Stern Investor Relations, Inc., 212-362-1200, hannahd@sternir.com; Media Relations: Dan Quinn, Ten Bridge Communications, Inc., 781-475-7974, dan@tenbridgecommunications.com